NDT Pharmaceuticals Inc.

OTC: NDTP · Healthcare · Biotechnology

PublicHQ Vienna, VACIK 0001329944Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 67

v0.1 · 5/100 weight · pillars only

↑ Altman-Z, listing tenure · ↓ filing timeliness, Piotroski F

Methodology →

Revenue TTM

$122.3k

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

—

Market cap

$73.5M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

NDT Pharmaceuticals Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

MindWalk Holdings Corp.——Atlantic International Corp.39D Cue Biopharma, Inc.50D electroCore, Inc.56C

Key facts

CEOJames Hovis

SectorHealthcare

IndustryBiotechnology

HeadquartersVienna, VA

ExchangeOTC: NDTP

Employees—

IPO date2008-01-22

Latest filings

10-Q2019-10-30 8-K2019-10-28 8-K2008-07-25 10-Q2008-05-14 10-K2008-04-08 8-K2007-11-05 8-K2007-09-11 8-K2007-06-08

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.